BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 12475252)

  • 1. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L; Tanaka M; Wait R; Shi YE; Brew K; Nagase H
    Biochemistry; 2002 Dec; 41(50):15025-35. PubMed ID: 12475252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain.
    Kai HS; Butler GS; Morrison CJ; King AE; Pelman GR; Overall CM
    J Biol Chem; 2002 Dec; 277(50):48696-707. PubMed ID: 12374789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2.
    Olson MW; Gervasi DC; Mobashery S; Fridman R
    J Biol Chem; 1997 Nov; 272(47):29975-83. PubMed ID: 9368077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).
    Xu X; Mikhailova M; Chen Z; Pal S; Robichaud TK; Lafer EM; Baber S; Steffensen B
    Matrix Biol; 2011 Sep; 30(7-8):404-12. PubMed ID: 21839835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway.
    Morrison CJ; Butler GS; Bigg HF; Roberts CR; Soloway PD; Overall CM
    J Biol Chem; 2001 Dec; 276(50):47402-10. PubMed ID: 11584019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB; Wei S; Bahudhanapati H; Kota S; Acharya KR; Brew K
    Protein Sci; 2007 Sep; 16(9):1905-13. PubMed ID: 17660250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
    Lee MH; Rapti M; Knaüper V; Murphy G
    J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
    Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
    J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of inductive effects of different concentrations of cyclosporine A on MMP-1, MMP-2, MMP-3, TIMP-1, and TIMP-2 in fetal and adult human gingival fibroblasts.
    Nazemisalman B; Sajedinejad N; Darvish S; Vahabi S; Gudarzi H
    J Basic Clin Physiol Pharmacol; 2019 Mar; 30(3):. PubMed ID: 30913036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
    Jia Y; Hu DN; Sun J; Zhou J
    Curr Eye Res; 2017 Apr; 42(4):600-603. PubMed ID: 28402202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.
    Remacle AG; Shiryaev SA; Radichev IA; Rozanov DV; Stec B; Strongin AY
    J Biol Chem; 2011 Jun; 286(23):21002-12. PubMed ID: 21518756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long-term marrow cultures.
    Marquez-Curtis LA; Dobrowsky A; Montaño J; Turner AR; Ratajczak J; Ratajczak MZ; Janowska-Wieczorek A
    Br J Haematol; 2001 Dec; 115(3):595-604. PubMed ID: 11736941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and localization of selected matrix metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors (TIMP-2 and -3) in follicular cysts of sows.
    Grzesiak M; Kaminska K; Knapczyk-Stwora K; Hrabia A
    Theriogenology; 2022 Jun; 185():109-120. PubMed ID: 35395587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
    Young KA; Hennebold JD; Stouffer RL
    Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases-2 and -9 and their endogenous tissue inhibitors in tissue remodeling after sealing of the fetal membranes in a sheep model of fetoscopic surgery.
    Devlieger R; Riley SC; Verbist L; Leask R; Pijnenborg R; Deprest JA
    J Soc Gynecol Investig; 2002; 9(3):137-45. PubMed ID: 12009387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
    Li H; Simon H; Bocan TM; Peterson JT
    Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.